PGP and ovarian carcinoma: Besides, co-expression of YB-1 and P-gp may be a promising relevant biomarker for unfavorable prognosis in ovarian cancer [39], the interventional effect of YB-1 on GSP regulating P-gp expression in ovarian cancer cells is also unknown yet.